NASHVILLE, Tenn. (AP) -- Vanderbilt-Ingram Cancer Center in Nashville has begun a line of mutation testing for breast cancer patients.
Such patients will now have their breast tumor tissue tested for gene mutations important for treatment decisions.
Information from genetic tests will then be used to match each patient to the best cancer therapies available, including drugs in early clinical trials.
Routine mutation screening already is done for all lung cancer and melanoma patients.
(Copyright 2011 by The Associated Press. All Rights Reserved.)
To comment, the following rules must be followed:
Comments may be monitored for inappropriate content, but the station is under no legal obligation to do so.
If you believe a comment violates the above rules, please use the Flagging Tool to alert a Moderator.
Flagging does not guarantee removal.
Multiple violations may result in account suspension.
Decisions to suspend or unsuspend accounts are made by Station Moderators.
Links require admin approval before posting.
Questions may be sent to firstname.lastname@example.org. Please provide detailed information.
Viewers with disabilities can get assistance accessing this station's FCC Public Inspection File by contacting the station with the information listed below. Questions or concerns relating to the accessibility of the FCC's online public file system should be directed to the FCC at 888-225-5322, 888-835-5322 (TTY), or email@example.com.